Serum tryptophan binding in chlorpromazine-treated chronic schizophrenics.
D002746:Chlorpromazine / Q000494:pharmacology / Q000627:therapeutic use*; D002908:Chronic Disease; D004058:Diffusion; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008297:Male; D009966:Orphenadrine / Q000494:pharmacology / Q000627:therapeutic use; D011485:Protein Binding; D012559:Schizophrenia / Q000097:blood* / Q000188:drug therapy / Q000378:metabolism; D012709:Serum Albumin / Q000378:metabolism; D013997:Time Factors; D014364:Tryptophan / Q000097:blood*; D014366:Tryptophan Oxygenase / Q000378:metabolism
D005230:Fatty Acids, Nonesterified; D012709:Serum Albumin; D014364:Tryptophan; D009966:Orphenadrine; D014366:Tryptophan Oxygenase; D002746:Chlorpromazine